评估运动激励与皮质类固醇注射对膝骨关节炎益处的多中心随机对照试验方案(MOVE-OK)
该方案设计了一项在美國退伍军人事务部(VA)医疗系统四个中心开展的实用型析因交叉随机双盲安慰剂对照试验,计划纳入220例膝骨关节炎患者,评估游戏化社会激励促进运动及皮质类固醇注射镇痛改善功能的效果,主要结局为日均步数变化和KOOS评分变化。
要点
- 游戏化社会激励对比仅提供Fitbit的对照组,主要结局为日均步数变化。
- 盲法皮质类固醇注射与仅利多卡因注射随机顺序交叉,主要结局为KOOS评分变化。
- 随访8个月,使用Way to Health平台在兩個四周间隔收集活动监测与患者报告结局。
核心结论
- 该试验将实用性地评估基于行为强化游戏化的激励能否改善该患者群体的体力活动,以及皮质类固醇注射能否减轻膝骨关节炎患者的疼痛和功能障碍。
- 试验结果将有助于指导临床实践并为管理指南提供信息。
研究设计与样本
- 实用型析因交叉随机对照试验,双盲、安慰剂对照,2阶段交叉设计。
- 从美国退伍军人事务部(VA)医疗系统四个中心的临床实践中招募经提供者认定符合膝关节注射条件且能无辅助装置行走的膝骨关节炎患者,共220例参与者将随机分组。
主要发现
- 主要结局为日均步数较基线的变化和膝关节骨关节炎结局评分(KOOS)较基线的变化。
- 使用活动监测器持续收集步数、心率和睡眠数据,并通过Way to Health(WTH)平台在8个月随访期间的兩個四周间隔收集患者报告结局。
- 分析将采用纳入所有可用数据点的混合效应回归。
临床怎么用
- 原文未据此给出推荐。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Knee osteoarthritis (KOA) is a high-priority problem among the aging population. While exercise has been shown to be beneficial in management of the disease, scalable and low-cost interventions to improve exercise in this population are lacking. Recent controversy over the value of corticosteroid injections for palliation has also arisen. Therefore, we designed a randomized, double-blind, placebo-controlled clinical trial with a 2-period crossover design to study (1) behavioral incentives to promote exercise and (2) corticosteroid injections to reduce pain and improve function in patients with KOA when compared to lidocaine only. METHODS: The study design is a pragmatic factorial and crossover randomized clinical trial. Patients with KOA who are deemed eligible by their provider to receive knee injections and are able to walk without assistive devices will be recruited from clinical practices at four sites within the Veterans Affairs (VA) Health System in the USA. In total, 220 participants will be randomized to receive social incentives with gamification (i.e., incorporation of game elements) to promote exercise and compared to controls that receive a Fitbit but no incentive. Each patient will also be assigned to receive a blinded corticosteroid injection and a lidocaine-only injection in random order. The primary outcomes are the change in average daily step counts from baseline and the change in Knee Osteoarthritis Outcome Score (KOOS) from baseline. The study team will continuously collect step count, heart rate, and sleep data using activity monitors and patient-reported outcomes using the Way to Health (WTH) platform at two four-week intervals over eight months of follow-up. Mixed effects regression incorporating all available data points will be used for analysis. DISCUSSION: The "Marching on for Veterans with Osteoarthritis of the Knee" (MOVE-OK) trial will take a pragmatic approach to evaluate (1) whether incentives based on behaviorally enhanced gamification can improve physical activity in this patient population and (2) whether corticosteroids injections reduce pain and disability in patients with KOA. Results of this trial will help to direct clinical practice and inform management guidelines. TRIAL REGISTRATION: ClinicalTrials.gov NCT05035810 . Registered on 5 September 2021.
引用
- Leach W, Doherty C, Olave M, et al. Protocol for a multi-center randomized controlled trial to evaluate the benefits of exercise incentives and corticosteroid injections in osteoarthritis of the knee (MOVE-OK). Trials. 2022. PMID: 35897080. doi:10.1186/s13063-022-06529-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。